• 研究課題をさがす
  • 研究者をさがす
  • KAKENの使い方
  1. 課題ページに戻る

2015 年度 実績報告書

Restoring tissue homeostasis by regulating TGF-beta signaling by using macrocyclic peptides

研究課題

研究課題/領域番号 15H06073
研究機関筑波大学

研究代表者

HIPOLITO CHRIS  筑波大学, 医学医療系, 助教 (20759914)

研究期間 (年度) 2015-08-28 – 2017-03-31
キーワードmacrocyclic peptides / in vitro selection / RaPID system / receptors
研究実績の概要

The goal of this research is the identification of macrocyclic-peptide ligands that can be used as agonist or antagonists for a specific signaling pathway. For the selection of macrocyclic peptides that bind to BMP signaling pathway receptors, the in vitro translation system used for the production of macrocyclic peptides was reconstituted with some modifications. The in vitro translation system was made from a combination of commercial products and in-lab prepared reagents, which is simpler than the method used by the Suga Lab, where all components are produced in-lab, and will hopefully make this technology more accessible to other academic labs. Using clones from previous selections, we established that macrocyclic peptides could be produced in the University of Tsukuba using a combination of commercial products from New England Biolabs and biomolecules prepared in our lab, namely the ribozyme flexizyme. Accurate production of the intended macrocyclic peptide was confirmed using MALDI analysis. In addition, the production of a linear peptide library and a corresponding macrocyclic-peptide library was also produced and verified. The in vitro selection target, bone morphogenetic protein (BMP) receptor ALK1, was received from my collaborator, Dr. Wei Li, as a histidine-tagged DsbA fusion protein. Binding of the target to magnetic beads was confirmed. The typical in vitro selection for macrocyclic peptides usually requires 6 rounds of selection. I am currently on the fourth round of selection.

現在までの達成度 (区分)
現在までの達成度 (区分)

2: おおむね順調に進展している

理由

The in vitro selection for macrocyclic peptides that bind to ALK1 receptor is underway. My collaborators are still preparing the remaining selection targets, type 2 receptors BMPR2 and ActR2. I have just completed the fourth round of selection for ALK1-binding macrocyclic peptides. In round 1 to round 3 of selection, we expect little indication that the selection is moving forward smoothly. At the current stage in my previous selections, round 4, an increase in recovered cDNA, indicating the isolation of functional macrocyclic peptides, is usually observed. However, I have yet to see this increase. While this does not indicate that the selection is not proceeding, close examination of the library at this stage is warranted. Toward this goal, the gene pools of various rounds have been translated into peptides and are awaiting examination using MALDI analysis. The mass of dominant clones will be observable above the background signal of the random peptide library if the selection is proceeding correctly. Furthermore, the individual sequences can be identified using next-generation sequencing. Selections against other protein targets are being performed in parallel, and these serve as controls for the anti-ALK1 selection. These controls will facilitate the identification of any systematic error in the system.

今後の研究の推進方策

We are currently troubleshooting the ALK1 selection using previously selected clones from successful selections performed in the past. Specifically, the macrocyclic peptide clone MaL6 will be used in a binding assay against PfMATE. This and other systems identified in the Suga Lab at the University of Tokyo are reliable and will help identify any problems in the selection.

Upon optimization of the selection system using MaL6:PfMATE, we can restart the selection against ALK1 from any round if a complete restart is deemed unnecessary. Identification of the functional anti-ALK1 macrocyclic peptides will be performed using next-generation sequencing. Identified macrocyclic peptides will then be chemically synthesized and purified prior to being assayed for ALK1 binding and for inhibition of BMP signaling. We have already purchased an HPLC for the purification of the synthesized peptides. We are currently looking at several options for peptide synthesizers, with a preference for Biotage due to its ability to synthesize peptides in parallel. In addition, we are also planning on purchasing a rotary evaporator and a lyophilizer for drying the purified peptides.

  • 研究成果

    (5件)

すべて 2016 2015

すべて 雑誌論文 (3件) (うち国際共著 1件、 査読あり 2件) 学会発表 (2件) (うち国際学会 2件、 招待講演 1件)

  • [雑誌論文] In Vitro Selected Macrocyclic Peptides: Tools for Regulating the Conformational Freedom of Transmembrane Proteins.2016

    • 著者名/発表者名
      Hipolito CJ, Nishio K, Suga H.
    • 雑誌名

      Yakugaku Zasshi

      巻: 136(2) ページ: 191-196

    • DOI

      10.1248/yakushi.15-00229-4

    • 査読あり
  • [雑誌論文] Combined Use of Oligopeptides, Fragment Libraries, and Natural Compounds: A Comprehensive Approach To Sample the Druggability of Vascular Endothelial Growth Factor.2016

    • 著者名/発表者名
      Bayo;-Puxan N, Rodriguez-Mias R, Goldflam M, Kotev M, Ciudad S, Hipolito CJ, Varese M, Suga H, Campos-Olivas R, Barril X, Guallar V, Teixidó M, Garcia J, Giralt E.
    • 雑誌名

      ChemMedChem

      巻: 11(8) ページ: 928-939

    • DOI

      10.1002/cmdc.201500467

    • 査読あり / 国際共著
  • [雑誌論文] Selection-based discovery of macrocyclic peptides for the next generation therapeutics.2015

    • 著者名/発表者名
      Morioka T, Loik ND, Hipolito CJ, Goto Y, Suga H.
    • 雑誌名

      Curr Opin Chem Biol

      巻: 26 ページ: 34-41

    • DOI

      10.1016/j.cbpa.2015.01.023.

  • [学会発表] Targeting ABC transporters with macrocyclic peptides.2015

    • 著者名/発表者名
      Hipolito CJ, Beis K, Suga H
    • 学会等名
      International Conference on Circular Proteins.
    • 発表場所
      Moreton Island, Australia
    • 年月日
      2015-11-01 – 2015-11-04
    • 国際学会 / 招待講演
  • [学会発表] Macrocyclic peptide ligands that inhibit transporter function and improve protein crystallization.2015

    • 著者名/発表者名
      Hipolito, CJ, Suga H
    • 学会等名
      11th Australian Peptide Conference
    • 発表場所
      Pepper Salt Resort, NSW, Australia
    • 年月日
      2015-10-25 – 2015-10-30
    • 国際学会

URL: 

公開日: 2017-01-06  

サービス概要 検索マニュアル よくある質問 お知らせ 利用規程 科研費による研究の帰属

Powered by NII kakenhi